StockCall Scrutinizes Baxter Intl., CareFusion, Nanosphere, and Mindray Medical Intl.
StockCall Scrutinizes Baxter Intl., CareFusion, Nanosphere, and Mindray Medical Intl. PR Newswire LONDON, March 25, 2013 LONDON, March 25, 2013 /PRNewswire/ -- The Supreme Court last year upheld President Obama's Affordable Care Act (ACA), which means that the healthcare industry will be undergoing a major transformation. While supporters of ACA say that the reform will lead to an increase in insured individuals, which will eventually benefit the healthcare industry, critics say that rising costs due to the ACA will hurt research and development of new products. Medical instruments & supplies companies have been one of the biggest critics of the ACA as they are required to pay a tax on gross sales. For companies such as CareFusion Corporation (NYSE: CFN), Baxter International Inc. (NYSE: BAX), Nanosphere Inc. (NASDAQ: NSPH), and Mindray Medical International Ltd. (NYSE: MR), the key will be to reduce costs to offset the impact of the tax on gross sales. On Friday, medical instruments and supplies stocks finished mostly higher, tracking gains in the broad market. StockCall reviewed the Medical Instruments & Supplies industry and chose CFN, BAX, NSPH, and MR for its technical coverage. These free reports can be seen for free at http://www.stockcall.com/signup Shares of CareFusion Corporation rose sharply in trading on Friday, ending the day 1.43% higher at $34.68 after hitting a 52-week high of $34.70. CareFusion's shares have had an excellent run so far in the year, gaining more than 21%. The stock has seen a series of highs over the past one month, which is a strong bullish signal. The positive trend is further confirmed by the volume activity over the past three trading sessions. The stock's MACD has also crossed the signal line on the upside. Download the free research on CFN by signing up now at http://www.StockCall.com/CFN032513.pdf Baxter International Inc.'s shares also touched a 52-week high on Friday before finishing the day sharply higher. The stock rose to a 52-week high of $70.95 before finishing the day 1.26% higher at $70.94. The stock gained 2.20% for the week, outperforming the broad market. Shares of BAX have also broken through a key technical level. The stock's MACD has crossed above the signal line, which indicates that market sentiment is bullish on the stock. Register for today's free analysis on BAX at http://www.StockCall.com/BAX032513.pdf Shares of Nanosphere Inc. fell sharply in Friday's trading session even as the broad market rallied. The stock ended the day 5.17% lower at $2.20 after falling to an intra-day low of $2.10. Nanosphere's shares have fallen more than 7% in the last three sessions. The company's shares had an excellent run for over two weeks before seeing a pullback last week. The stock slipped after failing to break through $2.40 resistance level. Its MACD chart suggests that market sentiment has turned bearish on the stock. Shares of NSPH currently have support at around $2.20. Free report on NSPH can be accessed by registering at http://www.StockCall.com/NSPH032513.pdf Mindray Medical International Ltd's shares touched a 52-week high of $39.20 on Friday before finishing the day 0.59% higher at $39.02. The stock rose more than 1.60% last week, taking its gains for the year to nearly 21%. The company's shares have broken through $38 resistance level recently, which is a bullish signal. The stock's MACD is also trading above the signal line and the zero-line, further confirming the upbeat trend. Register with StockCall and download the research on MR for free at http://www.StockCall.com/MR032513.pdf About StockCall.com StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at http://www.stockcall.com SOURCE StockCall.com Contact: William T. Knight, Email: email@example.com, Contact Number: +1-646-396-9857 (9:00 am EST - 01:30 pm EST)